Advertisement

Topics

Schering Group Company Profile

21:42 EST 13th December 2018 | BioPortfolio

Responsible, sustainable business practices are a clear objective for Schering. While this means integrating ecological aspects, it also means fulfilling the growing expectations of many people with regard to social values, whilst balancing these with economic sustainability for our company. The challenge is to consider economic, ecological and social decisions on an equal basis as well as to put them into practice alongside each other.

Location

Muellerstr. 178
Berlin
13353
Germany

Contact

Phone: 49-30-468-11 11
Fax: 49-30-468-15305
Email: bDSB@schering.de


News Articles [672 Associated News Articles listed on BioPortfolio]

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

Merck & Co.: Merging With Schering-Plough and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Pamela Demain, Executive Director, Corporate Licensing at Merck & Co. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, th...

TerraGen, Schering-Plough Collaboration to Focus on Discovery of Anti-Infectives

TerraGen Discovery Inc. (Vancouver, BC, Canada) and Schering-Plough Research Institute (SPRI; Kenilworth, NJ) have established a second collaboration to discover novel anti-infective compounds...

Rapid Nutrition Secures Distribution Deal in Sri Lanka

EQS Group-News: Rapid Nutrition PLC / Key word(s): Miscellaneous 11.07.2018 / 08:00 Rapid Nutrition Secures Distribution Deal in Sri Lanka ("Rapid Nutrition" or "the Company")   Londo...

Researchers Get Atomic View of FPT Inhibitors in Action

Researchers at Schering-Plough Research Institute report what they say is the first atomic view showing how FPT inhibitors work...

PTV News: Nov 5, 2009

Top stories on November 5th, 2009: Merck complete Schering-Plough merger Novartis buys Chinese vaccine maker BioPad’s Joe Mosala Molete on South African biotech Pfizer on partnering: Doug Giordan...

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

PubMed Articles [1742 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4131 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Aim: to observe the graft versus tumor effect of Pegylated Interferonα-2b in patients with hematological malignancies relapsed after allogeneic hematopoietic stem cell transplantation (al...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Companies [1678 Associated Companies listed on BioPortfolio]

Schering Health Care Limited

Schering Health Care is the UK subsidiary of Schering AG, an international pharmaceutical company with headquarters located in Berlin, Germany.Schering is a global company, with over 150 subsidiaries ...

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Schering Group

Responsible, sustainable business practices are a clear objective for Schering. While this means integrating ecological aspects, it also means fulfilling the growing expectations of many people with r...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering-Plough

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each ...

More Information about "Schering Group" on BioPortfolio

We have published hundreds of Schering Group news stories on BioPortfolio along with dozens of Schering Group Clinical Trials and PubMed Articles about Schering Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering Group Companies in our database. You can also find out about relevant Schering Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record